128 results
Page 5 of 7
424B3
EX-10.2
820a4c xszwzuk
2 Nov 17
Prospectus supplement
12:00am
8-K
EX-10.1
s0xf4aa0
2 Nov 17
Nemus Bioscience Announces $2,000,000 Series F Preferred Stock Financing
12:00am
8-K
EX-10.2
qx8hfd
2 Nov 17
Nemus Bioscience Announces $2,000,000 Series F Preferred Stock Financing
12:00am
424B3
EX-10.1
p9222kp456r8h6
12 May 17
Prospectus supplement
12:00am
8-K
EX-10.1
iltuci7sq564k5h
4 May 17
Nemus Bioscience Announces $20 Million Series E
12:00am
424B3
EX-10
rnzj8m6f3vrq4b808e
20 Jan 17
Prospectus supplement
12:00am
8-K/A
EX-10.1
ltqmo02qr33og1q52x4z
20 Jan 17
Financial Statements and Exhibits
12:00am
424B3
EX-10.1
dzbvmc
20 Jan 17
Prospectus supplement
12:00am
8-K
EX-10.1
htulrx0o 0vgkpb
10 Jan 17
NEMUS Bioscience Announces Closing of $1,200,000 Preferred Stock Financing
12:00am
8-K
EX-10.1
0k1jkym9wny1uma80q
29 Dec 16
Nemus Bioscience Announces Preferred Stock Financing
12:00am
8-K
EX-10.2
i2j8u27 51iy
29 Dec 16
Nemus Bioscience Announces Preferred Stock Financing
12:00am
424B3
EX-10.1
9d9hzn9r
28 Oct 16
Prospectus supplement
12:00am
8-K
EX-10.1
isyd7
27 Oct 16
NEMUS Bioscience Announces Closing of $500,000 Preferred Stock Financing
12:00am
8-K
EX-10.1
osjsqvyndcyb
26 Oct 16
NEMUS Bioscience Announces $500,000 Preferred Stock Financing
12:00am
8-K
EX-10.2
szv59lo
26 Oct 16
NEMUS Bioscience Announces $500,000 Preferred Stock Financing
12:00am
8-K
EX-10.2
k5rxecp3dxqxqnqmune6
18 Dec 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
n01uni3jwlcr z263o4a
18 Dec 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
1z334j
22 Oct 15
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.1
lmn95 20l2u
21 Aug 15
NEMUS Bioscience Announces Closing of $5.0 Million Series B Financing Funding to finance development of NB1111 for the treatment of glaucoma
12:00am